Wen, Yongjian, Han, Chenxia, Liu, Tingting, Wang, Rui, Cai, Wenhao 
ORCID: 0000-0002-4328-3341, Yang, Jingyu, Liang, Ge, Yao, Linbo, Shi, Na, Fu, Xianghui et al (show 8 more authors)
(2020)
Chaiqin chengqi decoction alleviates severity of acute pancreatitis via inhibition of TLR4 and NLRP3 inflammasome: Identification of bioactive ingredients via pharmacological sub-network analysis and experimental validation.
Phytomedicine, 79.
p. 153328.
|
Text
1-s2.0-S0944711320301604-main.pdf - Published Version Download (11MB) | Preview |
Abstract
<h4>Background</h4>Chaiqin chengqi decoction (CQCQD) is a Chinese herbal formula derived from dachengqi decoction. CQCQD has been used for the management of acute pancreatitis (AP) in the West China Hospital for more than 30 years. Although CQCQD has a well-established clinical efficacy, little is known about its bioactive ingredients, how they interact with different therapeutic targets and the pathways to produce anti-inflammatory effects.<h4>Purpose</h4>Toll-like receptor 4 (TLR4) and the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome-mediated pro-inflammatory signaling pathways, play a central role in AP in determining the extent of pancreatic injury and systemic inflammation. In this study, we screened the bioactive ingredients using a pharmacological sub-network analysis based on the TLR4/NLRP3 signaling pathways followed by experimental validation.<h4>Methods</h4>The main CQCQD bioactive compounds were identified by UPLC-QTOF/MS. The TLR4/NLRP3 targets in AP for CQCQD active ingredients were confirmed through a pharmacological sub-network analysis. Mice received 7 intraperitoneal injections of cerulein (50 μg/kg; hourly) to induce AP (CER-AP), while oral gavage of CQCQD (5, 10, 15 and 20 g/kg; 3 doses, 2 hourly) was commenced at the 3rd injection of cerulein. Histopathology and biochemical indices were used for assessing AP severity, while polymerase chain reaction, Western blot and immunohistochemistry analyses were used to study the mechanisms. Identified active CQCQD compounds were further validated in freshly isolated mouse pancreatic acinar cells and cultured RAW264.7 macrophages.<h4>Results</h4>The main compounds from CQCQD belonged to flavonoids, iridoids, phenols, lignans, anthraquinones and corresponding glycosides. The sub-network analysis revealed that emodin, rhein, baicalin and chrysin were the compounds most relevant for directly regulating the TLR4/NLRP3-related proteins TLR4, RelA, NF-κB and TNF-α. In vivo, CQCQD attenuated the pancreatic injury and systemic inflammation of CER-AP and was associated with reduced expression of TLR4/NLRP3-related mRNAs and proteins. Emodin, rhein, baicalin and chrysin significantly diminished pancreatic acinar cell necrosis with varied effects on suppressing the expression of TLR4/NLRP3-related mRNAs. Emodin, rhein and chrysin also decreased nitric oxide production in macrophages and their combination had synergistic effects on alleviating cell death as well as expression of TLR4/NLRP3-related proteins.<h4>Conclusions</h4>CQCQD attenuated the severity of AP at least in part by inhibiting the TLR4/NLRP3 pro-inflammatory pathways. Its active ingredients, emodin, baicalin, rhein and chrysin contributed to these beneficial effects.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Acute pancreatitis, Inflammatory signaling pathways, Chaiqin chengqi decoction, Active ingredients, Pharmacology network analysis |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 07 Oct 2020 13:43 |
| Last Modified: | 18 Jan 2023 23:29 |
| DOI: | 10.1016/j.phymed.2020.153328 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3103836 |
Dimensions
Dimensions
